Pharmacokinetics in drug discovery and development
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Boca Raton
Name of Publisher, Distributor, etc.
CRC Press
Date of Publication, Distribution, etc.
2002
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
426 p. : ill. ; 24 cm
GENERAL NOTES
Text of Note
Includes bibliographical references and index
NOTES PERTAINING TO TITLE AND STATEMENT OF RESPONSIBILITY
Text of Note
Ronald D. Schoenwald
CONTENTS NOTE
Text of Note
Machine generated contents note: SECTION I Basic Principles -- Chapter 1 Basic Principles3 -- Ronald D. Schoenwald -- SECTION II Industrial and Regulatory Applications -- Chapter 2 PK/PD Approach33 -- Honghui Zhou -- Chapter 3 Pharmacokinetics and Metabolism in Drug Discovery -- and Preclinical Development75 -- Nishit B. Modi -- Chapter 4 Phase I, II, and III FDA Submissions 37 -- Mark G. Eller -- Chapter 5 Bioavailability and Bioequivalence 79 -- Veneeta Tandon -- SECTION III Clinical Applications -- Chapter 6 General Approaches to Clinical Pharmacokinetic Monitoring 511 -- Ronald A. Herman -- Chapter 7 Aminoglycosides and Other Antibiotics 721 -- Michael E. Klepser and Erika J. Ernst -- Chapter 8 Cardiovascular Agents931 -- John M. Dopp and Bradley G. Phillips -- Chapter 9 Psychotropic Agents 171 -- Paul J. Perry -- Chapter 01 Theophylline102 -- Bernd Meibohm -- Chapter 11 Anticonvulsant Agents 132 -- Gail D. Anderson -- SECTION IV Research Applications -- Chapter 21 Classical Modeling762 -- David W A. Bourne -- Chapter 31 Noncompartmental Modeling: An Overview 382 -- Ronald A. Herman -- Chapter 41 Physiologically Based Pharmacokinetic Models 592 -- James M. Gallo -- Chapter 51 Population Pharmacokinetics513 -- Jeffrey S. Barrett -- Chapter 61 The Linear Systems Approach 753 -- Peter Veng-Pedersen -- Index514